Serum TSH, thyroglobulin, and thyroidal disorders in atomic bomb survivors exposed in youth: 30-year follow-up study.
Follow-up examinations to determine the frequency of thyroidal disorders were conducted by the Radiation Effects Research Foundation (RERF) on individuals in Hiroshima and Nagasaki who were less than 20 yr of age at the time of exposure to the atomic bomb. Concentrations of serum thyroid stimulating hormone (TSH), thyroglobulin (TG), and anti-TG antibody 30 yr after exposure were also determined. Nontoxic uninodular goiter was found in 13 cases of the 100 + rad exposed group (n = 477) and in three cases of the nonexposed group (n = 501). The prevalence in the 100+ rad exposed group was significantly higher (chi-squared = 6.584, p less than 0.01). Thyroid cancer was found in eight exposed cases, all of whom were in the 100+ rad group, and the prevalence was significantly greater (chi-squared = 7.919, p less than 0.01). Regardless of the presence or absence of thyroid disorders, serum TSH and TG levels were not statistically different between the 100 rad + exposed and nonexposed groups. Although hypothyroidism was found in 23 of the total cases, there was no correlation between its development and exposure to ionizing irradiation.
D000293:Adolescent; D005260:Female; D005500:Follow-Up Studies; D006044:Goiter, Nodular / Q000097:blood / Q000209:etiology; D006801:Humans; D007564:Japan; D008297:Male; D009381:Neoplasms, Radiation-Induced / Q000097:blood; D009689:Nuclear Warfare; D011832:Radiation Injuries / Q000097:blood* / Q000209:etiology; D013954:Thyroglobulin / Q000097:blood*; D013959:Thyroid Diseases / Q000097:blood* / Q000209:etiology; D013964:Thyroid Neoplasms / Q000097:blood / Q000209:etiology; D013972:Thyrotropin / Q000097:blood*
D013972:Thyrotropin; D013954:Thyroglobulin